Spectrum Pharma Inc (NASDAQ:SPPI) shares traded 4.98% up during most recent session to reach at the closing price of $11.6. The stock exchanged hands 799952 shares versus average trading capacity of 1.41 Million shares, yielding a market cap of $1.21 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $29.25 within the next 52-weeks. The mean target projections are based on 4 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Spectrum Pharma Inc (NASDAQ:SPPI) high price target of $43 and with a conservative view have low price target of $21.

Cantor Fitzgerald “Initiates Coverage On” Spectrum Pharma Inc (NASDAQ:SPPI) in a research note issued to investors on 2/07/19 to Overweight with price target of $19.

Additionally on 11/12/18 B. Riley FBR “Maintained” Spectrum Pharma Inc (NASDAQ:SPPI) to Buy setting price target at $29 and on 8/31/18 B. Riley FBR “Maintained” the stock to Buy at $35. Furthermore on 12/18/17 B. Riley FBR “Initiates Coverage On” the stock to Buy at $26.

On the other hand the company has Relative Strength Index (RSI 14) of 55.15 along with Average True Range (ATR 14) of 0.57, Consequently Spectrum Pharma Inc (NASDAQ:SPPI)’s weekly and monthly volatility is 4.80%, 5.32% respectively. The company’s beta value is at 2.76.

In terms of Buy, Sell or Hold recommendations, Spectrum Pharma Inc (NASDAQ:SPPI) has analysts’ mean recommendation of 0. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Spectrum Pharma Inc (NASDAQ:SPPI)’s minimum EPS for the current quarter is at $-0.25 and can go high up to $-0.18. The consensus mean EPS for the current quarter is at $-0.21 derived from a total of 3 estimates from the analysts who have weighed in on projected earnings. However the company reported $-0.29 earnings per share for the same quarter during last year.

Previously Spectrum Pharma Inc (NASDAQ:SPPI) reported $-0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $-0.22 by $0.05. The company posted an earnings surprise of 22.7%.

Spectrum Pharma Inc (NASDAQ:SPPI)’s revenue estimates for the current quarter are $25.6 Million according to 4 number of analysts, for the current quarter the company has high revenue estimates of $27.2 Million in contradiction of low revenue estimates of $24.5 Million. For the current year the company’s revenue estimates are $104.18 Million compared to low analyst estimates of $102.6 Million and high estimates of $105.8 Million according to 4 number of analysts.

Currently Spectrum Pharma Inc (NASDAQ:SPPI)’s shares owned by insiders are 1.1%, whereas shares owned by institutional owners are 84.5%. However the six-month change in the insider ownership was recorded -10.6%, as well as three-month change in the institutional ownership was recorded 0.44%.

Spectrum Pharma Inc (NASDAQ:SPPI)’s trailing twelve month revenues are $108.5 Million, whereas its price to sales ratio for the same period is 11.17. Its book value per share for the most recent quarter is $2.75 while its price to book ratio for the same period is 4.22, as for as the company’s cash per share for the most recent quarter is $2.11, however its price to cash per share ratio for the same period is 5.5. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.